NCT03210818

Brief Summary

Extra-corporeal membrane oxygenation (ECMO) life support system can provide both cardiac and respiratory support to patients with heart and respiratory failure. It can save time for these patients to regain organ function or to receive transplantation. Both the investigators' team and Ince et al. from the Netherland found that the microcirculatory dysfunction is more severe in ECMO non-survivors. The next step of research is to find out the key factors that affect microcirculation in ECMO patients. Because the blood flow supplied by the venoarterial ECMO (VA-ECMO) is directly related to macrocirculation, this study aims to investigate the effect of adjustment of VA-ECMO blood flow on microcirculation. The investigators hope that the results of this study can help the medical team to improve the quality of ECMO care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 7, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

November 5, 2017

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 3, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2019

Completed
Last Updated

May 9, 2019

Status Verified

July 1, 2018

Enrollment Period

1.1 years

First QC Date

July 2, 2017

Last Update Submit

May 7, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Perfused small vessel density

    Perfused small vessel density \[PSVD\] measured by incident dark field video microscope

    Difference of PSVD between before and after adjustment of VA-ECMO blood flow within 24 hours after placement of VA-ECMO

Secondary Outcomes (4)

  • Perfused small vessel density

    Difference of PSVD between before and after adjustment of VA-ECMO blood flow on day 2 after placement of VA-ECMO

  • Perfused small vessel density

    Difference of PSVD between before and after adjustment of VA-ECMO blood flow within anticipated 72 hours before removal of VA-ECMO

  • Total small vessel density

    Difference of TSVD between before and after adjustment of VA-ECMO blood flow within 24 hours after placement of VA-ECMO

  • Proportion of perfused vessel

    Difference of PPV between before and after adjustment of VA-ECMO blood flow within 24 hours after placement of VA-ECMO

Interventions

Adjustment of blood flow of extra-corporeal membrane oxygenation life support

Eligibility Criteria

Age20 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who require venoarterial extra-corporeal membrane oxygenation (ECMO) life support

You may qualify if:

  • Patients who require venoarterial extra-corporeal membrane oxygenation (ECMO) life support

You may not qualify if:

  • who can not take an examination of sublingual microcirculation within 24 hours after placement of venoarterial ECMO support
  • Non-native speakers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 110, Taiwan

Location

MeSH Terms

Conditions

Shock

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Yu-Chang Yeh, MD, PhD

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2017

First Posted

July 7, 2017

Study Start

November 5, 2017

Primary Completion

December 3, 2018

Study Completion

April 30, 2019

Last Updated

May 9, 2019

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations